Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lubica Rauova

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Blood|February 25, 2012
"Radical" model of thrombosisLubica Rauova
Blood|July 29, 2021
Understanding VITT(ual) realityLubica Rauova, Mortimer Poncz
Blood|August 4, 2022
Platelets get particularLubica Rauova, Douglas B Cines
Blood|November 30, 2013
Bad (or good) things come in small packagesLubica Rauova, Douglas B Cines
Thrombosis Research|December 17, 2009
Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosisM Anna Kowalska, Lubica Rauova, Mortimer Poncz
Pathophysiology of Haemostasis and Thrombosis|July 21, 2006
The role of surface PF4: glycosaminoglycan complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT)Mortimer Poncz, Lubica Rauova, Douglas B Cines
Autoimmunity Reviews|August 14, 2018
Molecular and cellular pathogenesis of heparin-induced thrombocytopenia (HIT)Lubica Rauova, Gowthami Arepally, Mortimer Poncz, et al.
Thrombosis and Haemostasis|August 5, 2016
Role of monocytes and endothelial cells in heparin-induced thrombocytopeniaDaria Madeeva, Douglas B Cines, Mortimer Poncz, et al.
Research and Practice in Thrombosis and Haemostasis|July 22, 2024
Thioredoxin-related transmembrane protein 1 negatively regulates coagulation and phosphatidylserine exposureJunsong Zhou, Mario C Rico, Lubica Rauova, et al.
Thrombosis and Haemostasis|January 31, 2014
Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgeryAdam Cuker, Lubica Rauova, Douglas Bolgiano, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Blood|February 25, 2012
"Radical" model of thrombosisLubica Rauova
Blood|July 29, 2021
Understanding VITT(ual) realityLubica Rauova, Mortimer Poncz
Blood|August 4, 2022
Platelets get particularLubica Rauova, Douglas B Cines
Blood|November 30, 2013
Bad (or good) things come in small packagesLubica Rauova, Douglas B Cines
Thrombosis Research|December 17, 2009
Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosisM Anna Kowalska, Lubica Rauova, Mortimer Poncz
Pathophysiology of Haemostasis and Thrombosis|July 21, 2006
The role of surface PF4: glycosaminoglycan complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT)Mortimer Poncz, Lubica Rauova, Douglas B Cines
Autoimmunity Reviews|August 14, 2018
Molecular and cellular pathogenesis of heparin-induced thrombocytopenia (HIT)Lubica Rauova, Gowthami Arepally, Mortimer Poncz, et al.
Thrombosis and Haemostasis|August 5, 2016
Role of monocytes and endothelial cells in heparin-induced thrombocytopeniaDaria Madeeva, Douglas B Cines, Mortimer Poncz, et al.
Research and Practice in Thrombosis and Haemostasis|July 22, 2024
Thioredoxin-related transmembrane protein 1 negatively regulates coagulation and phosphatidylserine exposureJunsong Zhou, Mario C Rico, Lubica Rauova, et al.
Thrombosis and Haemostasis|January 31, 2014
Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgeryAdam Cuker, Lubica Rauova, Douglas Bolgiano, et al.
Pageof 7